Teladoc Health, Inc.
TDOC
$7.59
$0.141.88%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.86% | 0.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.86% | 0.40% | |||
| Cost of Revenue | -1.76% | -3.20% | |||
| Gross Profit | -0.48% | 2.04% | |||
| SG&A Expenses | -2.10% | -1.23% | |||
| Depreciation & Amortization | -4.98% | 5.84% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.37% | -0.93% | |||
| Operating Income | 22.98% | 16.21% | |||
| Income Before Tax | -24.24% | 63.67% | |||
| Income Tax Expenses | 90.79% | 57.47% | |||
| Earnings from Continuing Operations | -51.58% | 64.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -51.58% | 64.89% | |||
| EBIT | 22.98% | 16.21% | |||
| EBITDA | 299.21% | 129.84% | |||
| EPS Basic | -50.67% | 65.23% | |||
| Normalized Basic EPS | -4.57% | 30.38% | |||
| EPS Diluted | -50.67% | 65.23% | |||
| Normalized Diluted EPS | -4.57% | 30.38% | |||
| Average Basic Shares Outstanding | 0.58% | 1.01% | |||
| Average Diluted Shares Outstanding | 0.58% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||